New study suggests mastectomy could prevent thousands of breast cancer cases

A recent study suggests that increased breast removal surgeries might prevent many cancer cases.

Study finds more breast removal surgeries could prevent thousands of cancer cases

A new study indicates that thousands of breast cancer cases could be avoided if preventive mastectomy were more widely offered. Research suggests that about 6,500 cases could be averted each year in the UK alone if women at high risk, particularly those with certain genetic markers, were given the option of risk-reducing mastectomies. Currently, these surgeries are primarily available to women with BRCA1, BRCA2, and PALB2 genes. However, the study suggests other gene mutations like ATM, CHEK2, RAD51C, and RAD51D may also warrant consideration for mastectomy if combined with other risk factors like family history and mammogram density. The cost-effectiveness of this approach has been backed by an economic evaluation from Queen Mary University of London and LSHTM, leading researchers to push for expanded access to such surgeries.

This study highlights an important shift in how breast cancer risks are evaluated and managed. It opens a door for many women who may have previously felt unprotected under traditional guidelines. Yet, while extending surgical options could lead to significant reductions in cancer cases, it brings complex emotional and medical implications. Women must be fully informed of all available options, including non-surgical alternatives. This calls for a more nuanced approach within the healthcare system, ensuring that patients receive comprehensive support as they navigate these life-altering decisions.

Highlights

As awareness grows, healthcare systems must adapt to offer comprehensive support.